Literature DB >> 17989653

New law broadens FDA safety authority, renews user fees.

Jeffrey L Fox.   

Abstract

Mesh：

Year:  2007        PMID： 17989653     DOI： 10.1038/nbt1107-1189

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  REMS violations fines.

Authors:  Catherine Shaffer
Journal:  Nat Biotechnol       Date:  2009-12       Impact factor: 54.908

2.  Trade secrets in balance as agencies issue new transparency rules.

Authors:  Gunjan Sinha
Journal:  Nat Biotechnol       Date:  2011-02       Impact factor: 54.908

3.  Physician and Pharmacist Understanding of the Risk of Urinary Retention with Retigabine (Ezogabine): A REMS Assessment Survey.

Authors:  Lianna Ishihara; Melissa Beck; Sara Travis; Olusegun Akintayo; Neil Brickel
Journal:  Drugs Real World Outcomes       Date:  2015-10-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.